Effects of Invisalign Palatal Expander System
Treatment Effects of Invisalign Palatal Expander System and Hyrax Palatal Expander - A Randomized Controlled Trial
1 other identifier
interventional
120
1 country
1
Brief Summary
The aim of this study is to evaluate the effectiveness of Invisalign Palatal Expander system ingrowing patients. This study compares the treatment outcomes of Invisalign Palatal Expander system to conventional treatments through randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2024
CompletedStudy Start
First participant enrolled
May 10, 2024
CompletedFirst Posted
Study publicly available on registry
May 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 10, 2034
May 16, 2024
May 1, 2024
4 years
May 8, 2024
May 13, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Width change
Transverse changes on CBCTs
12-18 months
Arch width change
Arch width change measured on digital study casts
12-18 months
Secondary Outcomes (1)
Cephalometric changes
12-18 months
Study Arms (2)
Invisalign® Palatal Expander System
EXPERIMENTALInvisalign® Palatal Expander System will be delivered.
Hyrax-type maxillary expander
ACTIVE COMPARATORHyrax-type maxillary expander will be delivered. The Hyrax-type maxillary expander will include a midline self-locking screw, which is connected to the conventional molar bands or printed clasps, which are cemented on the maxillary first molars (or on the maxillary primary second molars), via 0.9 mm stainless-steel wire. The framework is soldered to the bands and extends on the palatal side to the primary canines or canines. The expander will be fabricated by a qualified laboratory technician
Interventions
Invisalign palatal expander system: The Invisalign® Palatal Expander System (AlignTechnology, inc.) is 3D-printed orthodontic device for maxillary expansion.
Hyrax expander: The Hyrax-type maxillary expander will include a midline self-locking screw. The expansion screw is connected to the conventional molar bands or printed clasps, which are cemented on the maxillary first molars (or on the maxillary primary second molars), via 0.9 mm stainless-steel wire. The framework is soldered to the bands and extends on the palatal side to the primary canines or canines. The expander will be fabricated by a qualified laboratory technician
Eligibility Criteria
You may qualify if:
- Mixed dentition phase with at least three nonmobile (stable) teeth which have more than 1/4 of primary molar root length left16 in either side
- Early permanent dentition stage and early permanent dentition but second permanent molars not yet fully erupted in the arch
- Unilateral or bilateral posterior cross bite patients; or Patients who have been diagnosed with transverse maxillary deficiency (Skeletal transverse discrepancy measured from the estimated center of resistances of the first molars17 ≤ - 3 mm);
- Patients with Class I or Class II skeletal relationship
- Subjects willing to consent to the trial
You may not qualify if:
- Any general medical health problems which may influence treatment
- Any craniofacial anomalies
- Skeletal Class III patients
- Mixed dentition patients with more than 2 heavily restored primary second or permanent first molars.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of the Pacific
San Francisco, California, 94103, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Heeyeon Suh
University of the Pacific
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
May 8, 2024
First Posted
May 16, 2024
Study Start
May 10, 2024
Primary Completion (Estimated)
May 10, 2028
Study Completion (Estimated)
May 10, 2034
Last Updated
May 16, 2024
Record last verified: 2024-05